Anti-Human IL17A Recombinant Antibody(Ixekizumab)
-
产品编号
YR1008
-
别名
科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab |
Catalog Number | YR1008 |
Molecular Name | Ixekizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG4 Kappa |
Formulation | PBS, pH7.5 |
Background | Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation. |
CAS Number | 1143503-69-8 |
Application | WB, IP, IF, FuncS, FCM, Neut, ELISA |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 146.16 kDa |
Target | IL17A[Homo sapiens] |